MX2009007188A - Uso de analogos de somatostatina en cefalalgia histaminica. - Google Patents
Uso de analogos de somatostatina en cefalalgia histaminica.Info
- Publication number
- MX2009007188A MX2009007188A MX2009007188A MX2009007188A MX2009007188A MX 2009007188 A MX2009007188 A MX 2009007188A MX 2009007188 A MX2009007188 A MX 2009007188A MX 2009007188 A MX2009007188 A MX 2009007188A MX 2009007188 A MX2009007188 A MX 2009007188A
- Authority
- MX
- Mexico
- Prior art keywords
- cluster headache
- somatostatin analogs
- somatostatin
- srif
- analog
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invención se refiere al uso de un análogo de somatostatina (SRIF) que tiene una alta afinidad de enlace con SSTR1,2,3,5 humano, o una sal farmacéuticamente aceptable del mismo para la preparación de una composición farmacéutica para el tratamiento de cefalalgia histamínica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07100010A EP1941902A1 (en) | 2007-01-02 | 2007-01-02 | Use of Somatostatin analogs in cluster headache |
PCT/EP2008/050006 WO2008081013A1 (en) | 2007-01-02 | 2008-01-02 | Use of somatostatin analogs in cluster headache |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009007188A true MX2009007188A (es) | 2009-07-14 |
Family
ID=37846227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009007188A MX2009007188A (es) | 2007-01-02 | 2008-01-02 | Uso de analogos de somatostatina en cefalalgia histaminica. |
Country Status (8)
Country | Link |
---|---|
US (2) | US20100069296A1 (es) |
EP (2) | EP1941902A1 (es) |
AU (1) | AU2008203708B2 (es) |
BR (1) | BRPI0806484A2 (es) |
CA (1) | CA2674186A1 (es) |
MX (1) | MX2009007188A (es) |
RU (1) | RU2009129597A (es) |
WO (1) | WO2008081013A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102031998B1 (ko) * | 2011-09-04 | 2019-10-14 | 가부시키가이샤 도우사 고가쿠 겐큐쇼 | 당쇄 부가 폴리펩티드 및 당해 폴리펩티드를 포함하는 의약 조성물 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9203769D0 (en) * | 1992-02-21 | 1992-04-08 | Sandoz Ltd | Improvements in or relating to organic compounds |
MY147327A (en) * | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
GB0018891D0 (en) * | 2000-08-01 | 2000-09-20 | Novartis Ag | Organic compounds |
WO2005041901A2 (en) * | 2003-11-03 | 2005-05-12 | Elixir Pharmaceuticals, Inc. | Therapeutics using somatostatin agonists |
-
2007
- 2007-01-02 EP EP07100010A patent/EP1941902A1/en not_active Ceased
-
2008
- 2008-01-02 MX MX2009007188A patent/MX2009007188A/es unknown
- 2008-01-02 RU RU2009129597/15A patent/RU2009129597A/ru not_active Application Discontinuation
- 2008-01-02 CA CA002674186A patent/CA2674186A1/en not_active Abandoned
- 2008-01-02 BR BRPI0806484-9A patent/BRPI0806484A2/pt not_active Application Discontinuation
- 2008-01-02 US US12/521,191 patent/US20100069296A1/en not_active Abandoned
- 2008-01-02 WO PCT/EP2008/050006 patent/WO2008081013A1/en active Application Filing
- 2008-01-02 EP EP08701194A patent/EP2114439A1/en not_active Ceased
- 2008-01-02 AU AU2008203708A patent/AU2008203708B2/en not_active Ceased
-
2011
- 2011-09-07 US US13/226,837 patent/US20110319329A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2008081013A1 (en) | 2008-07-10 |
US20100069296A1 (en) | 2010-03-18 |
EP2114439A1 (en) | 2009-11-11 |
CA2674186A1 (en) | 2008-07-10 |
AU2008203708A1 (en) | 2008-07-10 |
US20110319329A1 (en) | 2011-12-29 |
AU2008203708B2 (en) | 2011-12-01 |
RU2009129597A (ru) | 2011-02-10 |
BRPI0806484A2 (pt) | 2011-09-27 |
EP1941902A1 (en) | 2008-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200630336A (en) | Novel compounds | |
TW200621690A (en) | Novel compounds | |
TW200612892A (en) | Novel compounds | |
MXPA05010682A (es) | Compuestos novedosos. | |
TW200519075A (en) | Novel compounds | |
TW200745003A (en) | Novel compounds | |
CA3094580C (en) | Oral formulations of cytidine analogs and methods of use thereof | |
PH12014500923A1 (en) | Insulinotropic peptide derivative wherein its n-terminal amino acid is modified | |
UA95644C2 (ru) | Пиридазиноновые производные, фармацевтическая композиция и способ лечения заболеваний | |
MY158438A (en) | Antibodies against human angiopoietin 2 | |
MY147890A (en) | 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidaz0 [4,5-b] pyridin-5-amine derivatives and their use for the treatment of cancer | |
TW200732296A (en) | Novel compounds | |
MX2009009153A (es) | Pirano-pirazol-aminas. | |
UA98804C2 (ru) | Катехоламиновые производные и фармацевтическая композиция на их основе | |
TW200635597A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
MY148844A (en) | Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol | |
CY1113726T1 (el) | Χρηση της πασιρεοτιδης για την αντιμετωπιση της ενδογενους υπερινσουλιναιμικης υπογλυκαιμιας | |
MX2009009154A (es) | Derivados de espiro-pirano-pirazol. | |
IN2012DN02624A (es) | ||
TW200633711A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
IL164440A0 (en) | New pharmaceutical composition containing fibanserin polymorph a | |
SI2185561T1 (sl) | Derivati 1,2,3,4-tetrahidropirolo(1,2-alfa)pirazin-6-karboksamidov in 2,3,4,5-tetrahidropirolo(1,2-alfa)-diazepin-7-karboksamidov, njihova priprava in njihova terapevtska uporaba | |
UA104281C2 (ru) | Противоопухолевые аналоги пептидов, способ их получения и фармацевтическая композиция на них основе | |
MX2009007188A (es) | Uso de analogos de somatostatina en cefalalgia histaminica. | |
MX2010005936A (es) | Uso de analogos de somatostatina en meningioma. |